Rating History for Assertio Therapeutics (ASRT) by Brookline Capital Markets

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/3/2020 Sally Yanchus New Coverage Buy
(N/A)
3.50
(N/A)
1.00
(1.73)
73% Details